spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 14 November 2007
doi: 10.1242/jcs.011528


Journal of Cell Science 120, 4188-4196 (2007)
Published by The Company of Biologists 2007
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakajima, M.
Right arrow Articles by Hirota, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakajima, M.
Right arrow Articles by Hirota, T.

The complete removal of cohesin from chromosome arms depends on separase

Masato Nakajima1,2, Kazuki Kumada3, Katsuyoshi Hatakeyama2, Tetsuo Noda3, Jan-Michael Peters4 and Toru Hirota1,*

1 Department of Experimental Pathology, Cancer Institute of the Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan
2 Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
3 Department of Cell Biology, Cancer Institute of the Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan
4 Research Institute of Molecular Pathology (IMP), Vienna, Austria


Figure 1
View larger version (55K):
[in this window]
[in a new window]

 
Fig. 1. Preservation of chromosome arm cohesion/cohesin in MG132-arrested cells. (A) Schematic overview of the experimental procedure. Synchronized HeLa cells were released from early S phase and treated with 100 ng/ml nocodazole, 25 µM MG132 or the solvent DMSO at G2/M transition. Mitotic cells were collected at the indicated times (hours) after the treatment and chromosome morphology was analyzed by Giemsa staining. (B) Representative pictures of chromosomes in the absence (left panel; `open') or presence (right panel; `closed') of arm cohesion. Insets show magnified images of the single chromosomes in the boxed region. (C) Four-hundred prometaphase/metaphase cells were scored for arm status at each time-point; the results are summarized in the histogram. The dark-grey and white populations represents cells with open and closed arms, respectively, as exemplified in B. An unclassified population is shown in light grey. (D) HeLa cells that had been induced to express Scc1-Myc for 2 days were treated with nocodazole or MG132 for 2 hours to enrich mitotic cells, which were then collected and further incubated in a new dish for 2 hours in the presence of the respective drugs. For a control experiment, cells were treated with an equivalent amount of DMSO for 4 hours. Mitotic cells were shaken off, cytospun, fixed and stained with Myc antibodies. Representative Myc-staining patterns including `throughout chromosomes', `centromere enrichment' and `centromere predominant' are shown. (E) One-hundred prometaphase/metaphase cells, indicated by condensin-I-specific subunit CAP-G staining (not shown), were classified into three categories based on Myc-staining pattern as exemplified and colour-coded in D. An unclassified population is shown in grey. Bar, 10 µm.

 

Figure 2
View larger version (32K):
[in this window]
[in a new window]

 
Fig. 2. Persistence of sister chromatid cohesion on arms depends on a cohesin complex protected by Sgo1. (A) Schematic overview of synchronization and RNAi treatment. HeLa cells were transfected with a mock or siRNA to Sgo1 during synchronization by the double-thymidine-block protocol and 25 µM MG132 was added at G2/M transition. Mitotic cells were collected at the indicated times (hours) after MG132 treatment and analyzed by Giemsa staining of chromosome spreads. (B) Reduction of Sgo1 in the collected mitotic cells was assessed by immunoblot analysis. (C) Representative chromosomes with paired (left) or unpaired (right) sister chromatids are shown. Insets show magnified images of the single chromosome in the boxed regions. (D) Quantification results from 200 cells for each time-point are summarized in the histogram. The dark-grey and white population represents cells containing unpaired and paired chromatids, respectively. An unclassified population is shown in light grey.

 

Figure 3
View larger version (72K):
[in this window]
[in a new window]

 
Fig. 3. Localization of Sgo1 on chromosome arms. (A) HeLa cells expressing EGFP-tagged Sgo1 were synchronized with thymidine, and, at 9.5 hours after the release, cells were fixed and DNA was counterstained with DAPI. The left panels are representative pictures of prophase, prometaphase and metaphase cells from unperturbed mitosis. The right panels represent cells treated either with 3 µM of an Aurora B inhibitor, ZM447439, 100 ng/ml nocodazole or 25 µM MG132 for 1 hour before fixation. Note that some EGFP signals are discernible on chromosome arms (arrowheads) that are not clearly detectable in nocodazole-treated cells. (B) Total extract of nocodazole-arrested HeLa cells (lane 1) was fractionated into a chromosome-enriched fraction (lane 2) and a cytoplasmic fraction (lane 3). Each fraction was analyzed by immunoblotting with antibodies to Sgo1. Note that these antibodies specifically react with Sgo1 in the chromosome-enriched fraction (left). (Right panels) HeLa cells were transfected with siRNA to Sgo1 during thymidine treatment for 21 hours. At 9 hours after the release, cells were fixed with 4% paraformaldehyde and stained with antibodies to Sgo1. DNA was counterstained with DAPI. Note that signals on chromosome arms (arrowheads) were abolished by Sgo1 depletion (right).

 

Figure 4
View larger version (19K):
[in this window]
[in a new window]

 
Fig. 4. Separase is required for efficient dissociation of arm cohesion. (A) Experimental design using asynchronous cells. Immortalized fibroblasts derived from separase conditional-knockout mouse embryos were infected with adenovirus encoding Cre recombinase or beta-galactosidase (lacZ) at MOI 200. After 2 days, mitotic cells were collected following 1 hour of treatment with 100 ng/ml nocodazole (or with 25 µM MG132, as a control; data not shown) and incubated in the presence of nocodazole (or MG132) for another 0.5, 1 or 3 hours, when cells were fixed and chromosome spreads were stained with Giemsa. (B) Representative chromosome configurations with a normal number of chromatids (two chromatids; left panels) and diplochromosomes (four chromatids; right panels) are shown. Note that chromosomes appear V-shaped when arm cohesion is dissolved, because mouse chromosomes are acrocentric. Insets show magnification images of the chromosomes in the boxed regions. (C) Approximately 200 cells were assessed for arm cohesion and summarized. Note that diplochromosomes (four chromatids) appeared only in Cre-introduced separase-depleted cells, which were scored separately from chromosomes with two chromatids. (D) Experiment designed to enrich the first mitosis after separase depletion. At 10 hours after adenovirus infection, cells were treated with 1 µM aphidicholin for 24 hours to arrest cells at early S phase. At 7 hours after the release from aphidicholin, when many cells were in G2 phase, either 100 ng/ml nocodazole (Noc) or 25 µM MG132 were added and cells were incubated for 2-4 hours. Mitotic cells were collected and analyzed by chromosome spreading. (E) Quantification data of arm cohesion from the experiment in D. Approximately 200 cells with two chromatids were assessed for each time-point.

 

Figure 5
View larger version (46K):
[in this window]
[in a new window]

 
Fig. 5. Scc1 cleavage is required for the complete removal of cohesin from chromosome arms. (A) Induction of Scc1-Myc. Both wild-type and non-cleavable Scc1-Myc could be detected 24 hours after doxycycline addition. Scc1 antibodies recognize both endogenous and exogenous Scc1, as indicated. (B) Experimental protocol. HeLa cells that can inducibly express either wild-type or non-cleavable Scc1-Myc were induced of their expression by the addition of doxycycline for 40 hours. Mitotic cells enriched by 1 hour of treatment with 100 ng/ml nocodazole were collected and further incubated for 3 hours in the presence of nocodazole. (C) Representative images of wild-type and non-cleavable Scc1-Myc-expressing cells (top two panels). After a hypotonic treatment, cells were cytospun onto glass slides and immunostained with antibodies to the Myc epitope (not shown, but red in E) and the condensin I subunit CAP-G (green), and DNA was counterstained with DAPI (blue). Chromosomes in the boxed regions are magnified and shown as an example for arm-open or -closed chromosomes (bottom panels). (D) Quantification results from ~100 prometaphase cells for each experiment are summarized in the histogram. The cell population for the open and closed arms is shown in dark grey and white, respectively, and an unclassified population is in light grey. (E) The Scc1-Myc-positive prometaphase and metaphase cells were further classified accordingly to the distribution pattern of Scc1-Myc on chromosomes, as colour-coded. (F) One-hundred prometaphase/metaphase cells were classified into three categories based on Myc-staining pattern, as exemplified in E. An unclassified population is shown in grey. Bar, 10 µm.

 

Figure 6
View larger version (61K):
[in this window]
[in a new window]

 
Fig. 6. Decrease in securin levels in nocodazole-arrested cells. (A) Schematic overview of the experimental settings. Asynchronously grown HeLa cells were transfected with Cdc20 siRNA for 22 hours. To obtain a synchronous culture of mitotic cells, we first shook-off mitotic cells to remove cells that had already spent some time in mitosis, and then collected cells that entered and stayed in mitosis within the next 2 hours. Subsequently, cells were transferred to a growing medium containing 100 ng/ml nocodazole, incubated for another 1.5 hours, and analyzed by chromosome spreading and Giemsa staining. (B) Depletion of Cdc20 by RNAi. Total cell extracts were prepared from mitotic cells that were used in the experiment. (C) One-hundred prometaphase/metaphase cells were classified based on chromosome-arm status. The dark-grey and white populations represent cells with open and closed arms, respectively. An unclassified population is shown in light grey. (D) HeLa cells were synchronized at early S phase by the double-thymidine-block regimen and, at 6.5 hours after the release, cells were treated either with 100 ng/ml nocodazole or 25 µM MG132, or with the solvent DMSO. Total cell extracts were analyzed by immunoblotting with the indicated antibodies. In nocodazole-arrest experiments, we noticed a slight reduction in the protein levels of securin. Note that phospho-H3 first appears at 6 hours after the release in both nocodazole- and MG132-treated cells, as in DMSO-treated cells, suggesting that the timing of mitotic entry is not largely affected by these treatments.

 

Figure 7
View larger version (11K):
[in this window]
[in a new window]

 
Fig. 7. A model illustrating how dissociation of cohesin from chromosome arms is regulated.

 





© The Company of Biologists Ltd 2007